Landfar Bio-medicine Co., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 70.19 million compared to CNY 104.11 million a year ago. Revenue was CNY 70.43 million compared to CNY 109.78 million a year ago.

Net loss was CNY 8.97 million compared to net income of CNY 2.17 million a year ago. Basic loss per share from continuing operations was CNY 0.0288 compared to basic earnings per share from continuing operations of CNY 0.007 a year ago. Diluted loss per share from continuing operations was CNY 0.0288 compared to diluted earnings per share from continuing operations of CNY 0.007 a year ago.